Melittin liposomes surface modified with poloxamer 188: In vitro characterization and in vivo evaluation

Pharmazie

Volumn 66, Issue 5, 2011, Pages 362-367

  Tian, J L ^a   Ke, Xue ^a   Chen, Z ^a   Wang, C J ^a   Zhang, Y ^a   Zhong, T C ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; MELITTIN; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; FREEZE THAWING; IN VITRO STUDY; IN VIVO STUDY; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; RAT; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; LIPOSOMES; MALE; MELITTEN; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; POLOXAMER; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SURFACE-ACTIVE AGENTS; VASCULITIS; VEINS;

EID: 79957657095     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0327     Document Type: Article

References (18)

1. Amado E, Blume A, Kressler J (2009) Novel non-ionic block copolymers tailored for interactions with phospholipids. React Funct Polym 69: 450-456.
2. Castile JD, Taylor KMG (1999) Factors affecting the size distribution of liposomes produced by freeze-thaw extrusion. Int J Pharm 188: 87-95. (Pubitemid 29472463)
3. DeGrado WF, Musso GF, Lieber M., Kaiser ET, Kezdy FJ (1982) Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue. Biophys J 37: 329-338. (Pubitemid 12150026)
4. Immordino ML, Dosio F, Cattel L (2006) Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 1: 297-315.
5. Kostarelos K, Tadros TF, Luckham PF (1999) Physical conjugation of (tri-) block copolymers liposomes toward the construction of sterically stabilized vesicle systems. Langmuir 15: 369-376.
6. Lee MT, Chen FY, Huang HW (2004) Energetics of pore formation induced by membrane active peptides. Biochemistry 43: 3590-3599.
7. Liang XM, Mao GZ, Simon Ng KY (2005) Effect of chain lengths of PEO-PPO-PEOon small unilamellar liposome morphology and stability: an AFM investigation. J Colloid Interface Sci 285: 360-372.
8. Ling CQ, Huang G XQ, Liu L (2001) The anti-tumor effect of melittin in vitro. Acad J Sec Mil Med Univ 22: 612-614.
9. Liu DZ, Hsieh YL, Chang SY, Chen WY (2003) Microcalorimetric studies on the physical stability of polyethylene glycol-grafted liposome. Colloid Surface A 212: 227-234.
10. Liu SJ, Yu M, He Y, Xiao L, Wang F, Song CC, Sun HS, Ling CQ, Xu ZH (2008) Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology 47: 1964-1973. (Pubitemid 351945563)
11. Maskarinec SA, Hannig J, Lee RC, Lee KYC (2002) Direct observation of poloxamer 188 insertion into lipid monolayers. Biophys J 82: 1453-1459. (Pubitemid 34204765)
12. Ranade VV (1989) Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers. J Clin Pharmacol 29: 685-694.
13. Romberg B, Hennink WE, Storm G (2008) Sheddable coatings for long-circulating nanoparticles. Pharm Res 25: 55-71.
14. Stark B, Pabst G, Prassl R (2010) Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure. Eur J Pharm Sci 41: 546-555.
15. Terra RM, Guimaraes JA, Verli H (2007) Structural and functional behavior of biologically active monomeric melittin. J Mol Graph Model 25: 767-772. (Pubitemid 46216111)
16. Tian JL, Zhao YZ, Jin Z, Lu CT, Tang QQ, Xiang Q, Sun CZ, Zhang L, Xu YY, Gao HS, Zhou ZC, Li XK, Zhang Y (2010) Synthesis and characterization of poloxamer 188-grafted heparin copolymer. Drug Dev Ind Pharm 36: 832-838.
17. Wang C, Chen TY, Zhang N, Yang MJ Li B, Lü X, Cao XT, Ling CQ (2009) Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating caMKII-tAK1-JNK/p38 and Inhibiting IκBα Kinase-NFκB. J Biol Chem 284: 3804-3813.
18. Woodle MC (1995) Sterically stabilized liposome therapeutics. Adv Drug Deliver Rev 16: 249-265.